A 4-week hep C cure? Bristol to test drugs with Gilead's Sovaldi
Friday, June 20, 2014 - 08:50
in Health & Medicine
NEW YORK (Reuters) - In the race to find a faster cure for hepatitis C, Bristol-Myers Squibb Co said it will test its experimental antiviral drug combination with Gilead Sciences Inc's blockbuster drug Sovaldi, hoping to cut treatment time to four weeks.